295 related articles for article (PubMed ID: 27200049)
41. Regulation of human erythrocyte Na+/H+ exchange by soluble and particulate guanylate cyclase.
Petrov V; Lijnen P
Am J Physiol; 1996 Nov; 271(5 Pt 1):C1556-64. PubMed ID: 8944639
[TBL] [Abstract][Full Text] [Related]
42. Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.
Gur S; Kadowitz PJ; Hellstrom WJ
Curr Pharm Des; 2010 May; 16(14):1619-33. PubMed ID: 20201788
[TBL] [Abstract][Full Text] [Related]
43. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
44. Properties and subcellular distribution of guanylate cyclase activity in rat renal medulla: correlation with tissue content of guanosine 3',5'-monophosphate.
Craven PA; DeRubertis FR
Biochemistry; 1976 Nov; 15(23):5131-7. PubMed ID: 10967
[TBL] [Abstract][Full Text] [Related]
45. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
Sutor B; Mantell K; Bacher B
Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the cyclic guanosine 3'-5' monophosphate system in human brain tumors.
Frattola L; Carenzi A; Cerri C; Kumakura K; Trabucchi M
Acta Neurol Scand; 1976 Nov; 54(5):382-90. PubMed ID: 11631
[TBL] [Abstract][Full Text] [Related]
47. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
48. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
[TBL] [Abstract][Full Text] [Related]
49. Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.
Ehsan A; Sommer F; Schmidt A; Klotz T; Koslowski J; Niggemann S; Jacobs G; Engelmann U; Addicks K; Bloch W
Cancer; 2002 Dec; 95(11):2293-301. PubMed ID: 12436434
[TBL] [Abstract][Full Text] [Related]
50. Tissue guanosine-3',5'-cyclic monophosphate levels and soluble guanylate cyclase activity: a positive correlation during unilateral cryptorchidism in the rat testis.
Spruill WA; Steiner AL; Earp HS
J Clin Invest; 1978 Sep; 62(3):568-76. PubMed ID: 29053
[TBL] [Abstract][Full Text] [Related]
51. A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway.
Wunder F; Stasch JP; Hütter J; Alonso-Alija C; Hüser J; Lohrmann E
Anal Biochem; 2005 Apr; 339(1):104-12. PubMed ID: 15766716
[TBL] [Abstract][Full Text] [Related]
52. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
Greenberg SS; Cantor E; Ho E; Walega M
J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
[TBL] [Abstract][Full Text] [Related]
53. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
54. Characterization and metabolism of cyclic guanosine 3'5'-monophosphate in Mycobacterium smegmatis.
Bhatnagar NB; Bhatnagar R; Venkitasubramanian TA
Biochem Biophys Res Commun; 1984 Jun; 121(2):634-40. PubMed ID: 6145417
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical localization of 3',5'-cyclic guanosine monophosphate in the canine proximal colon: responses to nitric oxide and electrical stimulation of enteric inhibitory neurons.
Shuttleworth CW; Xue C; Ward SM; de Vente J; Sanders KM
Neuroscience; 1993 Sep; 56(2):513-22. PubMed ID: 7504218
[TBL] [Abstract][Full Text] [Related]
56. Atrial natriuretic factor activates cyclic adenosine 3',5'-monophosphate phosphodiesterase in Xenopus laevis oocytes and potentiates progesterone-induced maturation via cyclic guanosine 5'-monophosphate accumulation.
Sandberg K; Bor M; Ji H; Carvallo PM; Catt KJ
Biol Reprod; 1993 Nov; 49(5):1074-82. PubMed ID: 8286573
[TBL] [Abstract][Full Text] [Related]
57. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells.
Stumpf I; Bazwinsky I; Peschke E
J Pineal Res; 2009 Mar; 46(2):140-7. PubMed ID: 19175857
[TBL] [Abstract][Full Text] [Related]
58. Identification of a novel protein with guanylyl cyclase activity in Arabidopsis thaliana.
Ludidi N; Gehring C
J Biol Chem; 2003 Feb; 278(8):6490-4. PubMed ID: 12482758
[TBL] [Abstract][Full Text] [Related]
59. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development.
Sanchez LS; de la Monte SM; Filippov G; Jones RC; Zapol WM; Bloch KD
Pediatr Res; 1998 Feb; 43(2):163-8. PubMed ID: 9475279
[TBL] [Abstract][Full Text] [Related]
60. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
